Fibroblast growth factor 23 and cardiovascular disease in chronic kidney disease; new trends

Azar Baradaran

doi:10.15171/jpd.2018.01

J Parathyr Dis. 2018;6(1): 1-2.
doi: 10.15171/jpd.2018.01

Abstract View: 2238

PDF Download: 1054

Epidemiology and Prevention

Fibroblast growth factor 23 and cardiovascular disease in chronic kidney disease; new trends

Azar Baradaran^*

¹ Nickan Research Institute, Isfahan, Iran.

*Corresponding Author: *Corresponding author: Prof. Azar Baradaran, , Email: azarbaradaran@med.mui.ac.ir

Abstract

Keywords: Calcium, Chronic kidney disease, Mineral bone disorder, Heart, Calcification, Fibroblast growth factor 23

Implication for health policy/practice/research/medical education

Increased serum fibroblast growth factor 23 is capable of increasing intracellular calcium in cardiomyocytes which lead to rise incidence of sudden cardiac death.

First Name

Last Name

Email Address

Comments

Security code

Generate New Image

Type the code from the image

Abstract View: 2239

years	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2024	20	19	20	18	21	31	17	28	43	40	18	30
2023	22	27	44	12	2	13	18	14	35	31	41	11
2022	29	22	19	35	23	24	17	24	23	33	26	34
2021	42	36	54	49	64	67	63	48	37	26	22	36
2020	36	32	50	42	54	44	52	175	127	57	40	45
2019										4	31	22